Testicular cancer surgery

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Gertrude Djouka, M.D.[2], Shanshan Cen, M.D. [3]

Testicular cancer Microchapters


Patient Information


Historical Perspective




Differentiating Testicular cancer from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis



History and Symptoms

Physical Examination

Laboratory Findings

X Ray




Other Imaging Findings

Other Diagnostic Studies



Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Testicular cancer surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Testicular cancer surgery

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Testicular cancer surgery

CDC on Testicular cancer surgery

Testicular cancer surgery in the news

Blogs on Testicular cancer surgery

Directions to Hospitals Treating Testicular cancer

Risk calculators and risk factors for Testicular cancer surgery


Surgery is the mainstay of treatment for testicular cancer. Radical inguinal orchiectomy is recommended for every patient with testicular cancer for cure and histology.


Radical inguinal orchiectomy

Retroperitoneal lymph node dissection

  • RPLND may be done at the same time as an orchiectomy, or it can be done later during another surgery.

Salvage surgery


  1. Nicolai N, Necchi A, Raggi D, Biasoni D, Catanzaro M, Piva L, Stagni S, Maffezzini M, Torelli T, Faré E, Giannatempo P, Pizzocaro G, Colecchia M, Salvioni R (February 2015). "Clinical outcome in testicular sex cord stromal tumors: testis sparing vs. radical orchiectomy and management of advanced disease". Urology. 85 (2): 402–6. doi:10.1016/j.urology.2014.10.021. PMID 25623702.
  2. Mosharafa AA, Foster RS, Bihrle R, Koch MO, Ulbright TM, Einhorn LH, Donohue JP (August 2003). "Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors?". Cancer. 98 (4): 753–7. doi:10.1002/cncr.11573. PMID 12910519.
  3. Silberstein JL, Bazzi WM, Vertosick E, Carver BS, Bosl GJ, Feldman DR, Bajorin DF, Motzer RJ, Al-Ahmadie H, Reuter VE, Sheinfeld J (August 2014). "Clinical outcomes of local and metastatic testicular sex cord-stromal tumors". J. Urol. 192 (2): 415–9. doi:10.1016/j.juro.2014.01.104. PMID 24518791.
  4. Foster RS, Donohue JP (June 2000). "Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma". J. Urol. 163 (6): 1788–92. PMID 10799183.
  5. Stephenson AJ, Sheinfeld J (2004). "The role of retroperitoneal lymph node dissection in the management of testicular cancer". Urol. Oncol. 22 (3): 225–33, discussion 234–5. doi:10.1016/j.urolonc.2004.04.029. PMID 15271322.
  6. "NCCN Clinical Practice Guidelines in Oncology: Testicular cancer. National comprehensive cancer network, 2019; https://www.nccn.org/professionals/physician_gls/pdf/testicular.pdf."

Template:WikiDoc Sources